Budget Amount *help |
¥17,030,000 (Direct Cost: ¥13,100,000、Indirect Cost: ¥3,930,000)
Fiscal Year 2017: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2016: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2015: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
|
Outline of Final Research Achievements |
IL-17-producing helper CD4+ T cells, Th17 cells, control not only host defense against pathogens but also immune pathogenesis of inflammatory and autoimmune diseases. Th17 cells differentiate from antigen-primed naive CD4+ T cells in response to IL-6, and the IL-6-receptor signaling plays a dominant role for the development of Th17 cells. In this study, we found that TRAF2 and TRAF5 associated with the signal-transducing receptor gp130 expressed by naive CD4+ T cells differentially regulated the instructive IL-6-receptor signaling that is needed for the development of Th17 cells.
|